Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status

Julia L Marcus1, Wendy A Leyden1, Chun R Chao2

  • 11 Kaiser Permanente Northern California , Oakland, California.

Insights

Hepatitis C virus (HCV) co-infection slows CD4 recovery and increases mortality in adults with HIV starting antiretroviral therapy (ART). Aggressive HCV treatment is recommended for all co-infected individuals, irrespective of sex.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Hepatitis C virus (HCV) co-infection and biological sex are potential factors influencing antiretroviral therapy (ART) response in HIV-infected individuals.
  • Limited research exists on the combined impact of HCV status and sex on HIV-associated outcomes.
  • Understanding these interactions is crucial for optimizing HIV management.

Purpose of the Study:

  • To investigate the effects of HCV co-infection and biological sex on CD4 cell count changes, viral load suppression, and survival in HIV-infected adults initiating ART.
  • To determine if HIV/HCV co-infection influences ART effectiveness differently based on sex.
  • To provide evidence for tailored treatment strategies in co-infected populations.

Main Methods:

  • A cohort study of 12,865 HIV-infected adults initiating ART between 1996-2011 was conducted.
  • Piecewise linear regression analyzed CD4 count changes over 5 years, stratified by sex and HCV status.
  • Cox regression assessed hazards for viral suppression (<500 copies/mL), AIDS, and death, considering sex and HCV co-infection.

Main Results:

  • HIV/HCV co-infected individuals (both men and women) exhibited slower CD4 count increases in the first year of ART compared to HIV-mono-infected individuals.
  • After 5 years, women maintained higher CD4 counts than men, irrespective of HCV status.
  • HIV/HCV co-infection was associated with a 40% increased mortality risk but did not significantly impact AIDS incidence or viral suppression rates compared to HIV mono-infection.

Conclusions:

  • HIV/HCV co-infected men and women experience impaired CD4 recovery and elevated mortality risk following ART initiation.
  • Biological sex influences CD4 count trajectories, with women generally showing better recovery.
  • Aggressive treatment of HCV in co-infected adults, regardless of sex, is strongly recommended to improve long-term outcomes.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.7K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
55
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.7K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
351
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
16.0K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
34